GLUTATHIONE MARKET, BY APPLICATION, 2021-2030 (USD MILLION) TABLE 22 FRANCE GLUTATHIONE MARKET, BY TYPE, 2021-2030 (USD MILLION) TABLE 23 FRANCE GLUTATHIONE MARKET, BY APPLICATION, 2021-2030 (USD MILLION) TABLE 24 ITALY GLUTATHIONE MARKET, BY TYPE, 2021-2030 (USD MILLION) TABLE 25 ITALY GLUTATHIONE MARKET, BY APPLICATION, 2021-2030 (USD MILLION) TABLE 26 SPAIN GLUTATHIONE MARKET, BY TYPE, 2021-2030 (USD MILLION) TABLE 27 SPAIN GLUTATHIONE MARKET, BY APPLICATION, 2021-2030 (USD MILLION) TABLE 28 REST OF EUROPE GLUTATHIONE MARKET, BY TYPE, 2021-2030 (USD MILLION) TABLE 29 REST OF EUROPE GLUTATHIONE MARKET, BY APPLICATION, 2021-2030 (USD MILLION) TABLE 30 ASIA PACIFIC GLUTATHIONE MARKET, BY COUNTRY, 2021-2030 (USD MILLION) TABLE 31 ASIA PACIFIC GLUTATHIONE MARKET, BY TYPE, 2021-2030 (USD MILLION) TABLE 32 ASIA PACIFIC GLUTATHIONE MARKET, BY APPLICATION, 2021-2030 (USD MILLION) TABLE 33 CHINA GLUTATHIONE MARKET, BY TYPE, 2021-2030 (USD MILLION) TABLE 34 CHINA GLUTATHIONE MARKET, BY APPLICATION, 2021-2030 (USD MILLION) TABLE 35 INDIA GLUTATHIONE MARKET, BY TYPE, 2021-2030 (USD MILLION) TABLE 36 INDIA GLUTATHIONE MARKET, BY APPLICATION, 2021-2030 (USD MILLION) TABLE 37 JAPAN GLUTATHIONE MARKET, BY TYPE, 2021-2030 (USD MILLION) TABLE 38 JAPAN GLUTATHIONE MARKET, BY APPLICATION, 2021-2030 (USD MILLION) TABLE 39 REST OF ASIA PACIFIC GLUTATHIONE MARKET, BY TYPE, 2021-2030 (USD MILLION) TABLE 40 REST OF ASIA PACIFIC GLUTATHIONE MARKET, BY APPLICATION, 2021-2030 (USD MILLION) TABLE 41 LATIN AMERICA GLUTATHIONE MARKET, BY COUNTRY, 2021-2030 (USD MILLION) TABLE 42 LATIN AMERICA GLUTATHIONE MARKET, BY TYPE, 2021-2030 (USD MILLION) TABLE 43 LATIN AMERICA GLUTATHIONE MARKET, BY APPLICATION, 2021-2030 (USD MILLION) TABLE 44 BRAZIL GLUTATHIONE MARKET, BY TYPE, 2021-2030 (USD MILLION) TABLE 45 BRAZIL GLUTATHIONE MARKET, BY APPLICATION, 2021-2030 (USD MILLION) TABLE 46 ARGENTINA GLUTATHIONE MARKET, BY TYPE, 2021-2030 (USD MILLION) TABLE 47 ARGENTINA GLUTATHIONE MARKET, BY APPLICATION, 2021-2030 (USD MILLION) TABLE 48 REST OF LATIN AMERICA GLUTATHIONE MARKET, BY TYPE, 2021-2030 (USD MILLION) TABLE 49 REST OF LATIN AMERICA GLUTATHIONE MARKET, BY APPLICATION, 2021-2030 (USD MILLION) TABLE 50 MIDDLE EAST AND AFRICA GLUTATHIONE MARKET, BY COUNTRY, 2021-2030 (USD MILLION) TABLE 51 MIDDLE EAST AND AFRICA GLUTATHIONE MARKET, BY TYPE, 2021-2030 (USD MILLION) TABLE 52 MIDDLE EAST AND AFRICA GLUTATHIONE MARKET, BY APPLICATION, 2021-2030 (USD MILLION) TABLE 53 SAUDI ARABIA GLUTATHIONE MARKET, BY TYPE, 2021-2030 (USD MILLION) TABLE 54 SAUDI ARABIA GLUTATHIONE MARKET, BY APPLICATION, 2021-2030 (USD MILLION) TABLE 55 UAE GLUTATHIONE MARKET, BY TYPE, 2021-2030 (USD MILLION) TABLE 56 UAE GLUTATHIONE MARKET, BY APPLICATION, 2021-2030 (USD MILLION) TABLE 57 SOUTH AFRICA GLUTATHIONE MARKET, BY TYPE, 2021-2030 (USD MILLION) TABLE 58 SOUTH AFRICA GLUTATHIONE MARKET, BY APPLICATION, 2021-2030 (USD MILLION) TABLE 59 REST OF MIDDLE EAST AND AFRICA GLUTATHIONE MARKET, BY TYPE, 2021-2030 (USD MILLION) TABLE 60 REST OF MIDDLE EAST AND AFRICA GLUTATHIONE MARKET, BY APPLICATION, 2021-2030 (USD MILLION) TABLE 61 COMPANY REGIONAL FOOTPRINT TABLE 62 COMPANY INDUSTRY FOOTPRINT TABLE 63 KYOWA HAKKO BIO (KIRIN HOLDINGS): PRODUCT BENCHMARKING TABLE 64 KYOWA HAKKO BIO (KIRIN HOLDINGS): WINNING IMPERATIVES TABLE 65 SHANDONG JINCHENG: PRODUCT BENCHMARKING TABLE 66 SHANDONG JINCHENG: WINNING IMPERATIVES TABLE 67 KOHJIN LIFE SCIENCES: PRODUCT BENCHMARKING TABLE 68 KOHJIN LIFE SCIENCES: WINNING IMPERATIVES TABLE 69 KAIPING BIOCHEMICAL PHARMACEUTICAL: PRODUCT BENCHMARKING TABLE 70 KAIPING BIOCHEMICAL PHARMACEUTICAL: WINNING IMPERATIVES TABLE 71 METEORIC BIOPHARMACEUTICALS PVT
J Amino Acids 2012:736837 Guloyan V, Oganesian B, Baghdasaryan N, Yeh C, Singh M, Guilford F, Ting YS, Venketaraman V (2020) Glutathione supplementation as an adjunctive therapy in COVID-19
Los efectos secundarios del glutatin son mnimos
RNA-seq and ChIP-seq reveal microplastics induce endothelial-mesenchymal transition via HK2-mediated histone lactylation in pulmonary hypertension
and S.M.C., T.Y
The transcription coactivator HTIF1 and a related protein are fused to the RET receptor tyrosine kinase in childhood papillary thyroid carcinomas
